Registered Nurses´ Association of Ontario
Page 9 of 17 Main Menu <<Back Next>>
Physician:_______________________
Date:_______________________
Pain Assessment for:________________
Pain Diagnosis:_______________________
Location of Pain(s):_______________________
Check the descriptor:
Resident’s behaviour:
Intensity (0-10) circle the pain number:
none
1
2
3
4
5
6
7
8
9
10
worst
Pattern:
If a new pain, how long has it been present?
_______________________
What makes it better?
_______________________
What makes it worse?
_______________________
Impact on ADL’s:
_______________________
Family support?
_______________________
Resident’s perception of what is causing the pain:
_______________________
Resident’s goal for pain control:(numerical score)
_______________________
(activity) ________________________
Drug, dosage and total number of doses of all analgesic medications in the past 24 hours:
(i.e. PRN, breakthrough and routine) (i.e. Tylenol #3®, Morphine [immediate release], MS contin® [long acting].)
_______________________
Drug, dosage and total number of doses of all adjuvant analgesic medications in the past 24 hours:
(i.e. PRN, breakthrough and routine) (i.e. Naproxin®, Elavil®, Ativan®, Gravol®, Tylenol® plain)
_______________________
Non-pharmacological interventions tried in the past:
_______________________
Suggestions for changes in management:
New meds/dosages/intervals:
_______________________
discontinue:
_______________________
Orders:
_______________________
Naprosyn is a registered trademark of Syntex, Elavil is a registered trademark of Merck Frosst, Ativan is a registered trademark of Wyeth-Ayerst, Gravol is a registered trademark of Horner, Tylenol is a registered trademark of McNeil Consumer Products.
Reprinted with Permission. Brignell, A. (ed) (2000). Guideline for developing a pain management program. A resource guide for long-term care facilities, 3rd edition.